Fortive Corporation reported first‑quarter 2026 results that exceeded expectations, with core revenue of $1.07 billion, up 7.7% year‑over‑year, and adjusted earnings per share of $0.70, a 25% increase from the $0.55 adjusted EPS reported in Q1 2025. Adjusted EBITDA rose 13% to $311 million, reflecting a 140‑basis‑point expansion of the adjusted EBITDA margin to just over 29%.
The growth was driven by the company’s two main operating segments. Intelligent Operating Solutions generated $743.2 million in revenue, up 7.6% on a reported basis and 5.2% on a core basis, while Advanced Healthcare Solutions produced $326.2 million, up 7.9% reported and 5.8% core. In comparison, Q1 2025 revenue was $993.1 million and adjusted EPS was $0.85, underscoring a clear acceleration in both top‑line and profitability.
Adjusted EBITDA margin expansion was largely attributable to operating leverage, cost‑control initiatives, and favorable foreign‑exchange movements, partially offset by investments in growth initiatives. Gross margin contracted 100 basis points year‑over‑year to just over 63% because of tariffs introduced the previous year, but pricing actions and productivity gains helped mitigate the impact.
Fortive reaffirmed its full‑year 2026 adjusted EPS guidance of $2.90 to $3.00, noting that the quarter’s performance is trending toward the upper end of the range. The company also completed $500 million of share repurchases in the quarter, bringing total buybacks since the launch of new Fortive in July 2025 to $1.8 billion.
President and CEO Olumide Soroye said, “Q1 represented a strong start to the year and another quarter of solid execution by our team. We delivered core revenue growth of ~5%, adjusted EBITDA growth of ~13%, and adjusted EPS growth of ~25%.” He added, “We continued to deliver on our commitment to disciplined capital allocation by completing an additional ~$500 million of share repurchases in the quarter, bringing our total buybacks in the three quarters since launching new Fortive to ~$1.8 billion.” Soroye also noted, “Looking ahead, we are reaffirming our full‑year 2026 adjusted EPS guidance range of $2.90 to $3.00, and we are currently trending toward the upper half of the range.” He concluded, “We are encouraged by early progress on all three pillars of our Fortive Accelerated strategy: profitable organic growth acceleration powered by FBS Amplified, disciplined capital allocation with a focus on best relative returns, and a commitment to building and maintaining investor trust.”
Investor sentiment was mixed after the release. While the earnings beat—$0.70 versus the consensus estimate of $0.64—was welcomed, concerns about tariff‑related margin pressure and the company’s prior‑year adjusted EPS of $0.85 tempered enthusiasm. Analysts highlighted the strong demand in core segments and the company’s disciplined capital allocation as positive drivers, but noted that the gross‑margin decline could weigh on future profitability if tariffs persist.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.